Intra-articular infliximab in patients with rheumatoid arthritis and psoriatic arthritis with monoarthritis resistant to local glucocorticoids. Clinical efficacy extended to patients on systemic anti-tumour necrosis factor α. Issue 12 (12th November 2008) - Conti, F; Ceccarelli, F; Priori, R; Iagnocco, A; Signore, A; Valesini, G